296 related articles for article (PubMed ID: 3006858)
21. Inhibition of a peripheral sympathetic-cholinergic system by presynaptic alpha 2-adrenoceptors.
Ito T; Koss MC
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):24-8. PubMed ID: 2897083
[TBL] [Abstract][Full Text] [Related]
22. Interaction between central alpha 1- and alpha 2-adrenoceptors on sympathetic tone in rats.
Huchet AM; Huguet F; Tsoucaris-Kupfer D; Legrand M; Narcisse G
Neuropharmacology; 1986 May; 25(5):509-14. PubMed ID: 3016587
[TBL] [Abstract][Full Text] [Related]
23. Dopamine receptor mediated hypothermic action of B-HT 920 in rats.
Verma A; Kulkarni SK
J Pharm Pharmacol; 1991 Jun; 43(6):421-4. PubMed ID: 1681056
[TBL] [Abstract][Full Text] [Related]
24. Rilmenidine-induced hypotension in conscious rabbits involves imidazoline-preferring receptors.
Sannajust F; Head GA
J Cardiovasc Pharmacol; 1994 Jan; 23(1):42-50. PubMed ID: 7511734
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular responses of sinoaortic-denervated rats to intracerebroventricular injection of alpha 1- and alpha 2-adrenoceptor agonists.
Ricci D; Taira CA; Enero MA
Eur J Pharmacol; 1992 Mar; 212(2-3):195-200. PubMed ID: 1350994
[TBL] [Abstract][Full Text] [Related]
26. B-HT 958, a new alpha-adrenoceptor agonist with a high pre/postsynaptic activity ratio.
Pichler L; Hörtnagl H; Kobinger W
Naunyn Schmiedebergs Arch Pharmacol; 1982 Aug; 320(2):110-4. PubMed ID: 6126817
[TBL] [Abstract][Full Text] [Related]
27. Failure of selective antagonists (CH-38083 and idazoxan) to distinguish between prejunctional and postjunctional alpha 2-adrenoreceptors.
Lonart G; Harsing LG; Folly G; Vizi ES
J Auton Pharmacol; 1989 Apr; 9(2):149-58. PubMed ID: 2565902
[TBL] [Abstract][Full Text] [Related]
28. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat.
Pifl C; Pichler L; Kobinger W; Hornykiewicz O
Eur J Pharmacol; 1988 Aug; 153(1):33-44. PubMed ID: 2463928
[TBL] [Abstract][Full Text] [Related]
29. The dopamine autoreceptor agonist B-HT 920 inhibits in vivo dopamine release into the cerebroventricular system of cats.
Pichler L; Pifl C; Hornykiewicz O; Kobinger W
Eur J Pharmacol; 1987 Mar; 135(2):239-42. PubMed ID: 2884121
[TBL] [Abstract][Full Text] [Related]
30. Centrally mediated cardiovascular effects of B-HT 920 (6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-[4,5-d]-azepine dihydrochloride), a hypotensive agent of the "clonidine type".
Pichler L; Kobinger W
J Cardiovasc Pharmacol; 1981; 3(2):269-77. PubMed ID: 6166798
[TBL] [Abstract][Full Text] [Related]
31. Characterization of mechanisms involved in presynaptic inhibition of sympathetic pressor effects induced by some 5-HT1 receptor antagonists.
Fernández MM; Calama E; Morán A; Martín ML; San Román L
J Auton Pharmacol; 2000; 20(5-6):313-23. PubMed ID: 11350497
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of postsynaptic D2- dopamine receptors by B-HT 958 is revealed by co-treatment with the D1- receptor agonist SKF 38393.
Andén NE; Grabowska-Andén M
J Pharm Pharmacol; 1989 Jul; 41(7):490-2. PubMed ID: 2570858
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
Sengupta S; Lokhandwala MF
J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
[TBL] [Abstract][Full Text] [Related]
34. Exercise-induced increases in plasma catecholamines and growth hormone are augmented by selective alpha 2-adrenoceptor blockade in man.
Struthers AD; Burrin JM; Brown MJ
Neuroendocrinology; 1986; 44(1):22-8. PubMed ID: 3024055
[TBL] [Abstract][Full Text] [Related]
35. Sympathoinhibitory action of rilmenidine in conscious sinoaortically denervated rats.
Mayorov D; Chernobelski M; Medvedev O
J Cardiovasc Pharmacol; 1993 Aug; 22(2):314-20. PubMed ID: 7692175
[TBL] [Abstract][Full Text] [Related]
36. Effect of centrally acting alpha-adrenergic agonists on sympathetic nervous system function in humans.
Brown MJ; Harland D; Murphy MB; Struthers AD
Hypertension; 1984; 6(5 Pt 2):II57-62. PubMed ID: 6150000
[TBL] [Abstract][Full Text] [Related]
37. Inhibition by 5,6-dihydroxy-2-dimethylaminotetralin (M7) of noradrenergic neurotransmission in the rabbit hypothalamus: role of alpha-2 adrenoceptors and of dopamine receptors.
Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1985 May; 233(2):459-65. PubMed ID: 2987485
[TBL] [Abstract][Full Text] [Related]
38. Primate cardiovascular responses mediated by dopamine receptors: effects of N,N-di-n-propyldopamine and LY171555.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1984 Apr; 229(1):132-8. PubMed ID: 6707929
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological properties of the enantiomers of idazoxan: possible separation between their alpha-adrenoceptor blocking effects.
Dabire H; Dausse JP; Mouille P; Fournier B; Cardot A; Meyer P; Schmitt H
Clin Exp Hypertens A; 1986; 8(3):387-409. PubMed ID: 2873908
[TBL] [Abstract][Full Text] [Related]
40. Study of the in vivo and in vitro cardiovascular effects of (+)-glaucine and N-carbethoxysecoglaucine in rats.
Orallo F; Fernández Alzueta A; Campos-Toimil M; Calleja JM
Br J Pharmacol; 1995 Apr; 114(7):1419-27. PubMed ID: 7606346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
